Veloxis Pharmaceuticals Announces Financial Results For The First Half 2012 ... Daily Markets The study is designed to explore whether a conversion of patients who have symptomatic tremor from treatment with standard immediate release twice-daily tacrolimus capsules to extended release once-daily LCP-Tacro™ tablets leads to a measurable ... |
